Elekta wins public tender to deliver advanced cancer care

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Elekta wins public tender to deliver advanced cancer care solutions to New Karolinska Solna (NKS)

STOCKHOLM, May 25, 2016 – Stockholm County Council (Sweden), announced today that Elekta has been awarded the public tender to exclusively equip the Radiation Therapy Department of its new, flagship hospital, the New Karolinska Solna (NKS). Tomas Puusepp, Elekta’s President and CEO, says: “As a Swedish corporation headquartered in Stockholm, and as a world leader in cancer care, we are delighted to be awarded this prestigious tender. We are fully committed to investing in research and innovation and in providing our state-of-the-art technology in collaboration with NKS, in order to strengthen cancer care in the Stockholm region. It is exciting to further expand and deepen our collaboration with Karolinska (NKS), the hospital where stereotactic radiotherapy originated. Karolinska is a visionary and a great partner to Elekta’s own pioneering spirit in research, development and clinical advancement to support cancer care throughout the world.” The agreement is expected to be formally signed during Elekta’s first fiscal quarter 2016/17 and the bulk of the installation will occur in April 2017. The final decision is pending a 10-day review process during which the decision can be appealed. # # # For further information, please contact: Gert van Santen, Group Vice President Corporate Communications, Elekta AB Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com Time zone: CET: Central European Time Tobias Bülow, Director Financial Communication, Elekta AB Tel: +46 722 215 017, e-mail: tobias.bulow@elekta.com Time zone: CET: Central European Time The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 07:30 CET on May 25, 2016. About Elekta Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives. Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LONGi's Four Paths to Global Green Development

Updated Category News Views 62

LONGi's Vision: A Cleaner, Greener Future Amidst the buzz at COP31 in Antalya, LONGi is making waves with promises of a cleaner future. They're not just throwing around eco-friendly slogans—this company's laying down real pathways to tackle climate change, one solar panel at a time. Aiming for Industrial Transformation LONGi's got their sights set on shaking up...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 363

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 421

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 149

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 469

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 283

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 92

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 34

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 431

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading

Top 5 Most Recently Viewed Articles

Investing in Kronos Worldwide: Why Now is the Time

Updated Category News Views 150

Why Kronos Worldwide is a Smart Investment Choice Kronos Worldwide, Inc. (NYSE: KRO) is poised to benefit from a rising demand for titanium dioxide (TiO2) and is experiencing less pricing pressure this year. The company's cost-saving strategies are expected to enhance profit margins, making this an excellent time to think about investing in KRO. With a promising outlook,...

Continue Reading
Old National Transforms Wealth Advisory Services for Clients

Updated Category News Views 333

Old National Unveils New Name for Wealth Advisory Division Old National Bancorp has made a notable change in its wealth advisory division by renaming Old National Investments to Old National Wealth Advisors (ONWA). This rebranding reflects the extensive range of services that the division's financial professionals offer to their clients. With a dedicated team of...

Continue Reading
Archer's Exciting Rebrand Elevates Their Meat Snack Lineup

Updated Category News Views 693

Archer Embraces a Fresh Brand Identity Fast-rising meat snack sensation, Archer, has undergone a significant transformation with a bold new brand identity that is sure to turn heads. Formerly known as Country Archer Provisions, Archer has introduced a streamlined name, a vibrant logo, and new packaging designed to enhance brand recognition and consumer engagement in a...

Continue Reading
Noveon Magnetics Secures $215 Million Investment for Growth

Updated Category News Views 290

Noveon Magnetics Secures Significant Investment to Enhance Manufacturing Noveon Magnetics, Inc., recognized as a prominent U.S. manufacturer of sintered rare earth permanent magnets, has successfully closed a remarkable $215 million Series C financing round. This initiative was led primarily by One Investment Management, who contributed $200 million. The funds will...

Continue Reading
Luckin Coffee Celebrates 30,000 Stores with New Flagship Concept

Updated Category News Views 253

Luckin Coffee Marks a Milestone with Its 30,000th Store In an impressive display of growth and innovation, Luckin Coffee, a leading retail coffee chain, has officially launched its 30,000th store, the Origin Flagship. This milestone highlights the brand's dedication to quality and sustainable practices, aimed at meeting the ever-evolving demands of coffee enthusiasts....

Continue Reading